Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding.
One problem in investigating group A streptococcal infections and virulence is the lack of appropriate in vivo models. In this study we introduce the chicken embryo model for determining virulence of Streptococcus pyogenes. We found that M protein positive strains, if administered intravenously, were highly virulent for 12-day-old chicken embryos. The LD50 of the strains tested could be correlated directly with the amount of cell wall exposed M protein, which has been determined by the capacity of streptococci to bind fibrinogen and by the ability of streptococci to survive in fresh normal human blood. The number of colony forming units (cfu) of M+ strains necessary to kill 50% of embryonated eggs was significantly lower (< 10(2) cfu) than for M-variants (> 10(4) cfu). Albumin and/or IgG binding streptococcal cells, which can also take place in proteins of the M protein family which do not bind to fibrinogen, did not show that clear correlation to the virulence in chicken embryos that did fibrinogen binding. Application of anti-streptococcal M protein antisera from chicken and rabbit reduced the lethality of the chicken embryos. In contrast, no correlation was found between lethality of chicken embryos and the in vitro production of erythrogenic toxins by the administered strains. Thus the results indicate that the presence of M-protein with its fibrinogen binding activity on the streptococcal cell surface is necessary for virulence of group A streptococci in the chicken embryo model.
Schmidt
K H
KH
University of Jena, Institute of Experimental Microbiology, FRG.
Wiesner
J
J
Gerlach
D
D
Reichardt
W
W
Ozegowski
J H
JH
Köhler
W
W
D000818:Animals; D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism; D002352:Carrier Proteins; D002642:Chick Embryo; D005098:Exotoxins / Q000633:toxicity; D005340:Fibrinogen / Q000378:metabolism*; D006820:Hyaluronic Acid / Q000633:toxicity; D007106:Immune Sera; D015151:Immunoblotting; D007928:Lethal Dose 50; D008070:Lipopolysaccharides / Q000633:toxicity; D008565:Membrane Proteins; D011485:Protein Binding / Q000502:physiology; D011817:Rabbits; D013290:Streptococcal Infections / Q000382:microbiology; D013297:Streptococcus pyogenes / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity*; D014774:Virulence
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D001798:Blood Proteins; D002352:Carrier Proteins; D005098:Exotoxins; D007106:Immune Sera; D008070:Lipopolysaccharides; D008565:Membrane Proteins; C117980:SpeA protein, Streptococcus pyogenes; C027951:erythrogenic toxin; C014689:streptococcal M protein; D005340:Fibrinogen; D006820:Hyaluronic Acid